| Literature DB >> 35713769 |
Hanan El-Halaby1, Ashraf Bakr2, Mohamed El-Assmy1, Hussein Abdelaziz Abdalla3, Marwa Salem4, Riham Eid5.
Abstract
This study aimed to evaluate available volume status assessment tools in nephrotic syndrome (NS). Sixty children with INS were subdivided into hypovolemic and nonhypovolemic groups based on fractional excretion of sodium (FeNa%); all were studied for inferior vena cava collapsibility index (IVCCI), plasma atrial natriuretic peptide (ANP), and body composition monitor (BCM). Forty-four patients had nonhypovolemic and 16 had hypovolemic states. ANP did not differ between both groups. IVCCI was higher in hypovolemic group (p < 0.001) with sensitivity 87.5% and specificity 81.8% for hypovolemia detection, while BCM overhydration (BCM-OH) values were higher in nonhypovolemic group (p = 0.04) with sensitivity = 68.2% and specificity = 75% for detection of hypervolemia. FeNa% showed negative correlation with IVCCI (r = -0.578, p < 0.001) and positive correlation with BCM-OH (r = 0.33, p = 0.018), while FeNa% showed nonsignificant correlation to ANP concentration. IVCCI is a reliable tool for evaluating volume status in NS and is superior to BCM.Entities:
Keywords: Atrial natriuretic peptide; Body composition monitor; Children; Inferior vena cava; Intravascular volume; Nephrotic syndrome
Mesh:
Substances:
Year: 2022 PMID: 35713769 PMCID: PMC9569288 DOI: 10.1007/s12098-022-04177-1
Source DB: PubMed Journal: Indian J Pediatr ISSN: 0019-5456 Impact factor: 5.319
Clinical and laboratory data of hypovolemic vs. nonhypovolemic patients with active INS at the time of initial enrollment in the study and after resolution of edema
| Hypovolemic patients ( | Nonhypovolemic patients ( | ||
|---|---|---|---|
| Age at diagnosis (years) | 3.08 ± 1.3 | 3.8 ± 2.01 | 0.2 |
| Age at enrollment (years) | 6.2 ± 2.5 | 6.5 ± 2.9 | 0.76 |
| Duration of illness (month) | 39.3 ± 27.4 | 33.25 ± 28.4 | 0.46 |
| Sex: male/female | 8/8 | 38/6 | |
| Type of NS (clinical situation at enrollment) | |||
| First attack | 2 | 30 | |
| SDNS | 0 | 4 | |
| FRNS | 2 | 2 | |
| SRNS | 12 | 8 | |
| Degree of edema | 0.18 | ||
| Puffy eyes + LL edema + Ascites | 5 | 20 | |
| As 1 + Scrotal or vulval edema | 8 | 22 | |
| 1 or 2 + Pleural effusion | 3 | 2 | |
| Outcome of edema: Resolved | 13 | 43 | |
| Nonresolved | 3 | 1 | |
| Percentage of weight reduction until edema resolution (%) | 16.9 ± 11.3 | 11.1 ± 7.04 | |
| SBP (mm Hg) at the time of enrollment | 105.3 ± 10.5 | 111.4 ± 12.2 | |
| DBP (mm Hg) at the time of enrollment | 71.6 ± 14.2 | 71.05 ± 12.2 | 0.88 |
| Heart rate (/m) at the time of enrollment | 94.2 ± 10.5 | 89.8 ± 9.7 | 0.13 |
| Serum albumin (g/dL) | 1.95 ± 0.48 | 1.7 ± 0.26 | |
| Serum creatinine (mg/dL) | 0.46 ± 0.14 | 0.58 ± 0.2 | |
| Serum Na (mEq/L) | 131.4 ± 5.6 | 137.3 ± 5.4 | |
| BUN (mg/dL) | 19.4 ± 3.3 | 16.2 ± 4.1 | |
| FeNa (%) | 0.16 ± 0.12 | 1.59 ± 0.67 | |
| Plasma ANP (pg/mL) | 132.97 ± 59.2 | 127.9 ± 51.7 | 0.7 |
| Hemoglobin (g/dL) | 13.1 ± 1.3 | 11.1 ± 12 | |
| Hematocrit (%) | 43.8 ± 3.3 | 37.8 ± 7.9 | |
| Expiratory IVC diameter (mm) | 9.9 ± 2.9 | 10.04 ± 1.58 | 0.8 |
| Inspiratory IVC diameter (mm) | 4.7 ± 0.5 | 6.99 ± 1.52 | |
| IVCCI on admission | 48.97 ± 10.2 | 30.37 ± 10.98 | |
| BCM-OH | 1.5 (1.95)* | 2.2 (1.9)* |
*presented as median and interquartile range
Bold values indicate statistically significant values (below 0.05)
ANP Atrial natriuretic peptide, BCM Body composition monitor, BUN Blood urea nitrogen, DBP Diastolic blood pressure, FRNS Frequent relapsing nephrotic syndrome, FeNa% Fractional excretion of sodium, IVC Inferior vena cava, IVCCI Inferior vena cava collapsibility index, NS Nephrotic syndrome, OH Over hydration, SBP Systolic blood pressure, SDNS Steroid-dependent nephrotic syndrome, SRNS Steroid-resistant nephrotic syndrome